Drusolv Therapeutics, Inc.
New Filing
CIK: 0001923102·Pharmaceuticals·PENNSYLVANIA·Filed: Apr 12, 2022
Total Offering
$2,000,000
Amount Sold
$500,000
Investors
1
First Sale
Mar 31, 2022
Offering Details
- Type
- Debt, Security to be Acquired, Other: Convertible Notes. The notes are convertible into Common or Preferred Stock of the Company.
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Year Incorporated
- 2017
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| John G. Edwards | Related Person |
Company
SEC Filing
0001923102-22-000001
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free